Conclusion: Our results clearly confirm that tigecycline has an excellent activity against multi-resistant gram-positive, both tetracycline-susceptible and resistant isolates, possessing three different tetracycline-resistant genes and other determinants including mec and VanA, B together and suggesting that this drug may play an important role in the treatment of infections caused by gram-positive pathogens.